Literature DB >> 15194213

Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma.

Tomoko Hashimoto1, Kenichiro Uchida, Naoko Okayama, Yuji Imate, Yutaka Suehiro, Yuichiro Hamanaka, Yoshiya Ueyama, Fumihiko Shinozaki, Hiroshi Yamashita, Yuji Hinoda.   

Abstract

To explore the relation of the MMP-1 1G/2G and MMP-3 5A/6A promoter polymorphisms with head and neck squamous cell carcinoma (HNSCC), DNA specimens extracted from peripheral blood cells of HNSCC patients and healthy controls were genotyped. The frequency of the MMP-1 2G/2G genotype was significantly higher in HNSCC patients (n = 140) than in age- and sex-matched controls (n = 223) (P = 0.042; OR, 1.56). In the MMP-3 polymorphism, there was no significant difference in the genotype distribution between patients and controls. These data suggest that the MMP-1 promoter polymorphism may be associated with HNSCC. Copyright 2004 Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194213     DOI: 10.1016/j.canlet.2004.01.032

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  20 in total

1.  The polymorphism MMP1 -1607 (1G>2G) is associated with a significantly increased risk of cancers from a meta-analysis.

Authors:  Lili Lu; Yujiao Sun; Yiqun Li; Ping Wan
Journal:  Tumour Biol       Date:  2014-11-13

2.  Analysis of matrix metalloproteinase-1 gene polymorphisms and expression in benign and malignant breast tumors.

Authors:  Jing Zhou; Constance Brinckerhoff; Susan Lubert; Kui Yang; Jasmine Saini; Jeffrey Hooke; Richard Mural; Craig Shriver; Stella Somiari
Journal:  Cancer Invest       Date:  2011-11       Impact factor: 2.176

3.  Association between matrix metalloproteinase 1 -1607 1G>2G polymorphism and cancer risk: a meta-analysis including 19706 subjects.

Authors:  Guoda Han; Zhijiang Wei; Zhiliang Lu; Haibin Cui; Xiyong Bai; Huai'e Ge; Wei Zhang
Journal:  Int J Clin Exp Med       Date:  2014-09-15

4.  Genetic polymorphism of tumor necrosis factor alpha (TNF-α) and tumor necrosis factor beta (TNF-β) genes and risk of oral pre-cancer and cancer in North Indian population.

Authors:  Shalini Gupta; Kumud Nigam; Ratnesh Kumar Srivastav; Md Kaleem Ahmad; Abbas Ali Mahdi; Somali Sanyal
Journal:  Oral Maxillofac Surg       Date:  2021-03-29

Review 5.  Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.

Authors:  Ajay Kumar Chaudhary; Mamta Singh; Alok C Bharti; Kamlesh Asotra; Shanthy Sundaram; Ravi Mehrotra
Journal:  J Biomed Sci       Date:  2010-02-15       Impact factor: 8.410

6.  Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.

Authors:  Ajay K Chaudhary; Mamta Singh; Alok C Bharti; Mangal Singh; Shirish Shukla; Atul K Singh; Ravi Mehrotra
Journal:  BMC Cancer       Date:  2010-07-14       Impact factor: 4.430

7.  Identification of a cigarette smoke-responsive region in the distal MMP-1 promoter.

Authors:  Becky A Mercer; Alison M Wallace; Constance E Brinckerhoff; Jeanine M D'Armiento
Journal:  Am J Respir Cell Mol Biol       Date:  2008-07-10       Impact factor: 6.914

8.  No association between matrix metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and endometrial cancer risk.

Authors:  Alicia Beeghly-Fadiel; Yong-Bing Xiang; Sandra L Deming; Ji-Rong Long; Wang-Hong Xu; Qiuyin Cai; Wei Zheng; Xiao Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05-12       Impact factor: 4.254

9.  Matrix Metalloproteinases (MMP-2,-3,-9) Gene Polymorphisms in Cases of Benign Vocal Fold Lesions and Laryngeal Carcinoma.

Authors:  Vykintas Liutkevicius; Vaiva Lesauskaite; Rasa Liutkeviciene; Paulius Vaiciulis; Virgilijus Uloza
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

10.  Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.

Authors:  Caiyun Zhang; Chao Li; Minhui Zhu; Qingzhou Zhang; Zhenghua Xie; Gang Niu; Xicheng Song; Lei Jin; Guojun Li; Hongliang Zheng
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.